Progressive change of intra-islet GLP-1 production during diabetes development

Diabetes/Metabolism Research and Reviews

Volumn 30, Issue 8, 2014, Pages 661-668

  O'Malley, Thomas J ^a   Fava, Genevieve E ^a   Zhang, Yanqing ^a   Fonseca, Vivian A ^a   Wu, Hongju ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Diabetes; GLP 1; Islets; cells

Indexed keywords

GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; PCSK1 PROTEIN, MOUSE; PROPROTEIN CONVERTASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET CELL; PROTEIN EXPRESSION; UPREGULATION; ALGORITHM; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; IMPAIRED GLUCOSE TOLERANCE; METABOLISM; MUTANT MOUSE STRAIN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; PANCREAS ISLET ALPHA CELL; PATHOLOGY; PATHOPHYSIOLOGY; SECRETION (PROCESS);

ALGORITHMS; ANIMALS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-SECRETING CELLS; IMMUNOHISTOCHEMISTRY; ISLETS OF LANGERHANS; MALE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, MUTANT STRAINS; PREDIABETIC STATE; PROPROTEIN CONVERTASE 1; UP-REGULATION;

EID: 84901399050     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2534     Document Type: Article

References (32)

1. Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev 2007; 87(4): 1409-1439.
2. Marathe CS, Rayner CK, Jones KL, Horowitz M. Glucagon-like peptides 1 and 2 in health and disease: a review. Peptides 2013; 44: 75-86.
3. Meier JJ, Nauck MA. Glucagon-like peptide 1(GLP-1) in biology and pathology. Diab/Metab Res Rev 2005; 21(2): 91-117.
4. Meier JJ, Gallwitz B, Salmen S, et al. Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes. J Clin Endocrinol Metab 2003; 88(6): 2719-2725.
5. Meier JJ, Kemmeries G, Holst JJ, Nauck MA. Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects. Diabetes 2005; 54(7): 2212-2218.
6. Salehi M, Vahl TP, D'Alessio DA. Regulation of islet hormone release and gastric emptying by endogenous glucagon-like peptide 1 after glucose ingestion. J Clin Endocrinol Metab 2008; 93(12): 4909-4916.
7. Witte AB, Gryback P, Jacobsson H, et al. Involvement of endogenous glucagon-like peptide-1 in regulation of gastric motility and pancreatic endocrine secretion. Scand J Gastroenterol 2011; 46(4): 428-435.
8. Holst JJ, Christensen M, Lund A, et al. Regulation of glucagon secretion by incretins. Diab Obes Metab 2011; 13(Suppl 1): 89-94.
9. Patzelt C, Schiltz E. Conversion of proglucagon in pancreatic alpha cells: the major endproducts are glucagon and a single peptide, the major proglucagon fragment, that contains two glucagon-like sequences. Proc Natl Acad Sci U S A 1984; 81(16): 5007-5011.
10. Patzelt C, Tager HS, Carroll RJ, Steiner DF. Identification and processing of proglucagon in pancreatic islets. Nature 1979; 282(5736): 260-266.
11. Rouille Y, Westermark G, Martin SK, Steiner DF. Proglucagon is processed to glucagon by prohormone convertase PC2 in alpha TC1-6 cells. Proc Natl Acad Sci U S A 1994; 91(8): 3242-3246.
12. Dhanvantari S, Brubaker PL. Proglucagon processing in an islet cell line: effects of PC1 overexpression and PC2 depletion. Endocrinology 1998; 139(4): 1630-1637.
13. Rouille Y, Martin S, Steiner DF. Differential processing of proglucagon by the subtilisin-like prohormone convertases PC2 and PC3 to generate either glucagon or glucagon-like peptide. J Biol Chem 1995; 270(44): 26488-26496.
14. Shima K, Hirota M, Ohboshi C, Sato M, Nishino T. Release of glucagon-like peptide 1 immunoreactivity from the perfused rat pancreas. Acta Endocrinol 1987; 114(4): 531-536.
15. Uttenthal LO, Ghiglione M, George SK, Bishop AE, Polak JM, Bloom SR. Molecular forms of glucagon-like peptide-1 in human pancreas and glucagonomas. J Clin Endocrinol Metab 1985; 61(3): 472-479.
16. Heller RS, Aponte GW. Intra-islet regulation of hormone secretion by glucagon-like peptide-1-(7--36) amide. Am J Physiol 1995; 269(6 Pt 1): G852-G860.
17. Kilimnik G, Kim A, Steiner DF, Friedman TC, Hara M. Intraislet production of GLP-1 by activation of prohormone convertase 1/3 in pancreatic alpha-cells in mouse models of ss-cell regeneration. Islets 2010; 2(3): 149-155.
18. Marchetti P, Lupi R, Bugliani M, et al. A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets. Diabetologia 2012; 55(12): 3262-3272.
19. Ellingsgaard H, Hauselmann I, Schuler B, et al. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med 2011; 17(11): 1481-1489.
20. Liu Z, Stanojevic V, Avadhani S, Yano T, Habener JF. Stromal cell-derived factor-1 (SDF-1)/chemokine (C-X-C motif) receptor 4 (CXCR4) axis activation induces intra-islet glucagon-like peptide-1 (GLP-1) production and enhances beta cell survival. Diabetologia 2011; 54(8): 2067-2076.
21. Hansen AM, Bodvarsdottir TB, Nordestgaard DN, et al. Upregulation of alpha cell glucagon-like peptide 1 (GLP-1) in Psammomys obesus--an adaptive response to hyperglycaemia? Diabetologia 2011; 54(6): 1379-1387.
22. Whalley NM, Pritchard LE, Smith DM, White A. Processing of proglucagon to GLP-1 in pancreatic alpha-cells: is this a paracrine mechanism enabling GLP-1 to act on beta-cells? J Endocrinol 2011; 211(1): 99-106.
23. Mentlein R, Gallwitz B, Schmidt WE. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur J Biochem/FEBS 1993; 214(3): 829-835.
24. Bone RN, Icyuz M, Zhang Y, et al. Gene transfer of active Akt1 by an infectivity-enhanced adenovirus impacts beta-cell survival and proliferation differentially in vitro and in vivo. Islets 2012; 4(6): 366-378.
25. Zhang Y, Zhang Y, Bone RN, et al. Regeneration of pancreatic non-beta endocrine cells in adult mice following a single diabetes-inducing dose of streptozotocin. PLoS One 2012; 7(5): e36675.
26. Furuta M, Carroll R, Martin S, et al. Incomplete processing of proinsulin to insulin accompanied by elevation of Des-31, 32 proinsulin intermediates in islets of mice lacking active PC2. J Biol Chem 1998; 273(6): 3431-3437.
27. Zhu X, Orci L, Carroll R, Norrbom C, Ravazzola M, Steiner DF. Severe block in processing of proinsulin to insulin accompanied by elevation of des-64, 65 proinsulin intermediates in islets of mice lacking prohormone convertase 1/3. Proc Natl Acad Sci U S A 2002; 99(16): 10299-10304.
28. Lim GE, Brubaker P. Glucagon-like peptide 1 secretion by the L-cell. The view from within. Diabetes 2006; 55(suppl. 2): S70-S77.
29. Lim GE, Huang GJ, Flora N, LeRoith D, Rhodes CJ, Brubaker PL. Insulin regulates glucagon-like peptide-1 secretion from the enteroendocrine L cell. Endocrinology 2009; 150(2): 580-591.
30. Wu T, Rayner CK, Jones K, Horowitz M. Dietary effects on incretin hormone secretion. Vitam Horm 2010; 84: 81-110.
31. Poulsen MD, Hansen GH, Dabelsteen E, Hoyer PE, Noren O, Sjostrom H. Dipeptidyl peptidase IV is sorted to the secretory granules in pancreatic islet A-cells. J Histochem Cytochem 1993; 41(1): 81-88.
32. Bugliani M, Syed F, Suleiman M, et al. A local GLP-1 system in human pancreatic islets: the role of DPP-IV inhibition by MK-0626. Diabetes 2013; 62(Suppl. 1): A96.